Screening inherited metabolic disorder in children with intellectual disability and epilepsy Zeka Geriliği ve Epilepsisi Olan Çocuklarda Kalıtsal Metabolik Hastalık Taraması


Üstkoyuncu P. S., Güven A. S., Poyrazoğlu H. G., Gökay S., KARDAŞ F., Kendirci M., ...Daha Fazla

Turk Noroloji Dergisi, cilt.25, sa.3, ss.135-139, 2019 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.4274/tnd.galenos.2019.82608
  • Dergi Adı: Turk Noroloji Dergisi
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.135-139
  • Anahtar Kelimeler: Inherited metabolic disorder, epilepsy, intellectual disability, metabolic screening
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objective: To indicate the benefits of the screening of inherited metabolic disorders in patients with epilepsy, global developmental delay, and intellectual disability. Materials and Methods: The medical records of 1100 patients who were investigated for inherited metabolic disorders between March 2014 and June 2017 were evaluated. Five hundred patients with epilepsy and global developmental delay/intellectual disability with mild/moderate and non-specific neurologic findings were enrolled in the study. Results: Inherited metabolic disorders were detected in 7 of 500 patients (1.4%) with epilepsy and global developmental delay/intellectual disability. One patient was diagnosed as having tyrosinemia type-2, one had Menkes disease, one had mitochondrial disease, one had hyperphenylalaninemia, two siblings were diagnosed as having 3-methylcrotonyl Coa carboxylase deficiency, and one patient was diagnosed as having phenylketonuria. Conclusion: The prevalence of inherited metabolic disorders is higher in countries with a high consanguinity ratio such as Turkey. Lack of the regular screening in patients with mild/moderate and non-specific neurologic findings result in late diagnosis.